Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 11

    1.

    Physical activity and multiple sclerosis: new insights regarding inactivity.

    Sandroff BM, Dlugonski D, Weikert M, Suh Y, Balantrapu S, Motl RW.

    Acta Neurol Scand. 2012 Jan 3. doi: 10.1111/j.1600-0404.2011.01634.x. [Epub ahead of print]

    PMID:
    22211941
    [PubMed - as supplied by publisher]
    2.

    Brain involvement in neuromyelitis optica spectrum disorders.

    Chan KH, Tse CT, Chung CP, Lee RL, Kwan JS, Ho PW, Ho JW.

    Arch Neurol. 2011 Nov;68(11):1432-9.

    PMID:
    22084126
    [PubMed - indexed for MEDLINE]
    3.

    Natalizumab and impedance of the homing of CD34+ hematopoietic progenitors.

    Saure C, Warnke C, Zohren F, Schroeder T, Bruns I, Cadeddu RP, Weigelt C, Fischer U, Kobbe G, Hartung HP, Adams O, Kieseier BC, Haas R.

    Arch Neurol. 2011 Nov;68(11):1428-31.

    PMID:
    22084125
    [PubMed - indexed for MEDLINE]
    4.

    Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years.

    Kim SH, Kim W, Li XF, Jung IJ, Kim HJ.

    Arch Neurol. 2011 Nov;68(11):1412-20. Epub 2011 Jul 11.

    PMID:
    21747007
    [PubMed - indexed for MEDLINE]
    5.

    Th17 cells in multiple sclerosis express higher levels of JAK2, which increases their surface expression of IFN-γR2.

    Conti L, De Palma R, Rolla S, Boselli D, Rodolico G, Kaur S, Silvennoinen O, Niccolai E, Amedei A, Ivaldi F, Clerico M, Contessa G, Uccelli A, Durelli L, Novelli F.

    J Immunol. 2012 Feb 1;188(3):1011-8. Epub 2012 Jan 4.

    PMID:
    22219326
    [PubMed - in process]
    6.

    Diurnal rhythms are altered in a mouse model of multiple sclerosis.

    Buenafe AC.

    J Neuroimmunol. 2012 Feb 29;243(1-2):12-7. Epub 2011 Dec 30.

    PMID:
    22209286
    [PubMed - indexed for MEDLINE]
    7.

    Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes.

    Nagaishi A, Takagi M, Umemura A, Tanaka M, Kitagawa Y, Matsui M, Nishizawa M, Sakimura K, Tanaka K.

    J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1360-4. Epub 2011 Jun 10.

    PMID:
    21665917
    [PubMed - indexed for MEDLINE]
    8.

    Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study.

    Moodie J, Healy BC, Buckle GJ, Gauthier SA, Glanz BI, Arora A, Ceccarelli A, Tauhid S, Han XM, Venkataraman A, Chitnis T, Khoury SJ, Guttmann CR, Weiner HL, Neema M, Bakshi R.

    J Neurol Sci. 2012 Apr 15;315(1-2):49-54. Epub 2011 Dec 28.

    PMID:
    22209496
    [PubMed - in process]
    9.

    Changes at the nodal and perinodal axonal domains: a basis for multiple sclerosis pathology?

    Desmazières A, Sol-Foulon N, Lubetzki C.

    Mult Scler. 2012 Feb;18(2):133-7. Epub 2012 Jan 4. Review.

    PMID:
    22217583
    [PubMed - indexed for MEDLINE]
    10.

    Temporal evolution of remission following multiple sclerosis relapse and predictors of outcome.

    Hirst CL, Ingram G, Pickersgill TP, Robertson NP.

    Mult Scler. 2012 Jan 4. [Epub ahead of print]

    PMID:
    22217582
    [PubMed - as supplied by publisher]
    11.

    Selective immunoglobulin A deficiency is exceptionally associated with multiple sclerosis.

    Pereira LF, Gómez M, García Trujillo JA, Romero Chala S, Cámara Hijón C.

    Neurologia. 2012 Jun;27(5):316. Epub 2012 Jan 2. English, Spanish. No abstract available.

    PMID:
    22217523
    [PubMed - as supplied by publisher]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk